EA
PBYI icon

Emerald Acquisition’s Puma Biotechnology PBYI Stock Holding History

Emerald Acquisition’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$4.71M Sell
70,178
-40,610
-37% -$2.05M 0.01% 1245
2016
Q2 		$3.3M Buy
+110,788
New +$3.46M 0.01% 1580

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Emerald Acquisition's PBYI Position: Q3 2016 in Review

Emerald Acquisition reduced its Puma Biotechnology (PBYI) stake by 37% in Q3 2016, selling an estimated $2.05M and leaving 70,178 shares worth $4.71M. The position accounts for 0.01% of the portfolio, ranked #1245.

Emerald Acquisition first reported a position in PBYI in Q2 2016 and has held it in 2 quarters since. 149 funds tracked by Wall St. Rank hold PBYI as of Q3 2016.

  • Emerald Acquisition held 70,178 shares of Puma Biotechnology worth $4.71M as of Q3 2016.
  • Emerald Acquisition sold 40,610 Puma Biotechnology shares in Q3 2016, an estimated $2.05M.
  • Puma Biotechnology made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1245 holding.
  • Emerald Acquisition first reported a position in Puma Biotechnology in Q2 2016 and has held it in 2 quarters since.
  • 149 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.